Ligand Pharmaceuticals Incorporated (LGND) vs RadNet, Inc. (RDNT)

A side-by-side comparison of Ligand Pharmaceuticals Incorporated and RadNet, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — LGND vs RDNT

growth of $100 · dividends reinvested · last 10y
LGND +389.0% (+17.2%/yr)RDNT +844.7% (+25.2%/yr)RDNT compounded faster over this window
05001kStart $10020182020202220242026$489$945
LGND RDNT

LGND vs RDNT: by the numbers

  • •LGND is the larger company ($5.95B vs $5.53B market cap).
  • •LGND is profitable (67.88% net margin) while RDNT runs a net loss (-0.93%).
  • •RDNT grew revenue faster over the past five years (12.68% vs 2.92% CAGR).

Metrics side by side

Valuation

MetricLGNDRDNT
P/E ratio31.76N/A
Forward P/E31.91136.65
P/S ratio20.482.44
P/B ratio6.155.04
EV / EBITDA45.0221.70
FCF yield2.21%N/A

Profitability

MetricLGNDRDNT
Gross margin98.58%9.70%
Operating margin17.61%4.00%
Net margin67.88%-0.93%
ROE20.38%-1.93%
ROIC3.91%1.41%

Growth (annualized)

MetricLGNDRDNT
Revenue CAGR (5Y)2.92%12.68%
FCF CAGR (5Y)-0.49%N/A
Total return CAGR (5Y)30.72%19.72%

Frequently asked

Which has grown faster, LGND or RDNT?
Over the past five years, RDNT grew revenue faster — LGND at a 2.92% CAGR versus RDNT at 12.68%.
Is LGND or RDNT more profitable?
LGND runs the higher net margin — LGND at 67.88% versus RDNT at -0.93%.
How have LGND and RDNT total returns compared?
Over the past 10 years, LGND delivered 17.12% and RDNT delivered 25.20% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.